KRKA, dd, Novo mesto, AO,   

Film coated tablets, 250 mg and 500 mg.

Cream for external use, 1%.

Tablets, film-coated, 5 mg + 10 mg, 5 mg + 20 mg, 10 mg + 10 mg, 10 mg + 20 mg.

Film-coated tablets, 50 mg and 150 mg.

Capsules, 40 mg.

Capsules, 120 mg.

Capsules, 80 mg.

Tablets, film-coated, 10 mg, 20 mg and 40 mg.

Film-coated tablets, 320 mg.

Film-coated tablets, 40 mg, 80 mg and 160 mg.

Tablets, film-coated, 160 mg + 12.5 mg.

The tablets covered with a film cover, 320 mg + 12,5 mg, 320 mg + 25 mg.

Tablets coated with a film membrane, 80 mg + 12.5 mg.

Tablets, film-coated, 160 mg + 25 mg.

Tablets dispersible in the oral cavity, 25 mg, 50 mg and 100 mg.

Eye ointment 3%.

Lyophilizate for solution for infusion, 250 mg.

Capsules of prolonged action, 8 mg, 16 mg and 24 mg.

Syrup.

Syrup.

Suspension for oral administration for children 120 mg / 5 ml.

Tablets of 500 mg.

Granules for solution for oral administration, 120 mg + 10 mg.

Granules for solution for oral administration, 500 mg + 20 mg.

Solution for injection, 4 mg / ml.

Tablets, 0.5 mg.

Capsules are enteric, 30 mg and 60 mg.

Tablets, film-coated, 5 mg and 10 mg.

Tablets of prolonged action, film-coated, 150 mg, 200 mg and 300 mg.

Tablets, film-coated, 10 mg.

Solution for oral administration, 1 mg / ml.

Tablets, film-coated, 400 mg.

Film-coated tablets, 275 mg.

10 tablets in a blister pack made of PVC / aluminum foil. By 1 or 2 blister in a pack of cardboard along with instructions for use.

Film-coated tablets, 550 mg.

By 10 tablets in blister of PVC / aluminum foil. By 1 or

1 blister in a cardboard pack together with instructions for use.

Tablets with sustained release, 6.5 mg.

Tablets, coated with enteric coating, 20 mg, 40 mg.

Capsules, 320 mg.

Capsules.

Tablets of prolonged action, film-coated, 400 mg.

Solution for intravenous and intra-arterial administration, 20 mg / ml.

Tablets are dispersible in the oral cavity 4 mg, 8 mg.

For 7 or 10 tablets in a contour mesh package (blister) from the combined material OPA / Al / PVC and PET / aluminum foil (peel off foil).

4, 8, 12 contour cell packs (blisters) of 7 tablets or 3, 5, 6, 9, 10 contour cell packs (blisters) of 10 tablets together with instructions for use are placed in a pack of cardboard.

The film-coated tablets are 325 mg + 37.5 mg.

Tablets, film-coated, 5 mg + 10 mg, 10 mg + 10 mg, 5 mg + 15 mg, 10 mg + 15 mg, 5 mg + 20 mg, 10 mg + 20 mg.

Tablets are chewable, 500 mg.

Spray nasal dosed, 0.1 mg + 5 mg / dose.

100 doses of the preparation (10 ml) in a vial of high density polyethylene with a metering device (pump) and a transparent protective cap from the combined material.

1 The bottle together with the instruction for use is placed in a cardboard pack.

Spray nasal dosed [for children], 0.05 mg + 5 mg / dose.

100 doses of the preparation (10 ml) in a vial of high-density polyethylene with a metering device (pump) and a colored protective cap from the combined material.

1 The bottle together with the instruction for use is placed in a cardboard pack.

Tablets, 40 mg.

Tablets, 80 mg.

Long-acting capsules 0.4 mg. 10 capsules per blister. For 1,2, 3, 6, 9 and 20 blisters in a pack of cardboard along with instructions for use.

Tablets with prolonged release, film-coated, 0.4 mg.10 tablets are placed in a contour mesh package made of a combined material OBA / Al / PVC or PVC / PE / PVDC and aluminum foil.

1, 3, 6, 9 or 10 contour mesh packages together with the instruction for use are placed in a pack of cardboard.

Tablets, 20 mg, 40 mg, 80 mg.

Capsules of prolonged action, 200 mg and 350 mg.

Capsules enteric in solution 20 mg.

In production at AO "KRKA, dd, Novo mesto ", Slovenia:

Lyophilizate for the preparation of a solution for infusion in a vial of clear glass containing 40 mg of omeprazole, capped with a rubber stopper, an aluminum cap and a plastic protective cap.

Capsules enteric soluble 10 mg and 40 mg.

Suspension for injection, 7 mg / ml.

Tablets, 20 mg and 40 mg.

Concentrate for solution for infusion, 10 mg / ml.

Lozenges 100 mg.

10 lozenges in a blister. For 3 blisters, together with instructions for use, put in a pack of cardboard.

Tablets, 12.5 mg + 20 mg.

Solution for intravenous administration, 1.25 mg / ml.